ReviewAntibodies (Basel, Switzerland)2022

Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapies for the Treatment of Primary Brain Tumors.

Christopher W Mount et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.